Related Experiment Videos
Antisense oligodeoxynucleotides as therapeutic agents for chronic myelogenous leukemia
1Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
Antisense Research and Development
|January 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Coronavirus seasonality, respiratory infections and weather.
BMC infectious diseases·2021
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma.
British journal of cancer·2014
A re-evaluation of the impact of temperature and climate change on foodborne illness.
Epidemiology and infection·2009
Outbreaks of infectious disease associated with private drinking water supplies in England and Wales 1970-2000.
Epidemiology and infection·2003
An investigation into the microflora of heroin.
Journal of medical microbiology·2002
Bovine serum albumin is a major oligonucleotide-binding protein found on the surface of cultured cells.
Antisense research and development·1995
Antiviral activity of RNA molecules containing self-releasing ribozymes targeted to lymphocytic choriomeningitis virus.
Antisense research and development·1995
Digoxigenin-labeled phosphorothioate oligonucleotides: a new tool for the study of cellular uptake.
Antisense research and development·1995
Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery.
Antisense research and development·1995
The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries.
Antisense research and development·1995
DHHC21 is a STIM1 protein S-acyltransferase that modulates immune function in vivo.
Journal of cell science·2026
The hypusine circuit: eIF5A at the crossroads of polyamine metabolism, malignant progression, and therapeutic vulnerability.
Biochimica et biophysica acta. Reviews on cancer·2026